Table 3.
Variables | ΔTyG-3 |
||
---|---|---|---|
β | 95% CI | P value | |
Model 1 | |||
Gender | −0.427 | −0.712, −0.142 | .004a |
Age | 0.016 | 0.005, 0.027 | .004a |
Model 2 | |||
Gender | −0.422 | −0.708, −0.136 | .005a |
Age | 0.018 | 0.007, 0.029 | .001a |
BMI (kg/m2) | 0.005 | −0.032, 0.042 | .791 |
Interferon-alfa | 0.609 | 0.064, 1.155 | .029a |
Model 3 | |||
Gender | −0.312 | −0.590, −0.034 | .028a |
Age | 0.012 | 0.001, 0.023 | .031a |
BMI (kg/m2) | 0.013 | −0.022, 0.048 | .445 |
Interferon-alfa | 0.540 | 0.029, 1.051 | .039a |
ΔTC-3 | 0.217 | 0.069, 0.366 | .005a |
ΔHDL-3 | −0.477 | −0.881, −0.074 | .021a |
Abbreviations: β = regression coefficient; BMI = body mass index; HDL = high-density lipoprotein; TC = total cholesterol; TyG = triglyceride-glucose index.
ΔVariable-3 is the mean difference value of the variable between 3 months after discharge and at baseline. Linear regression analysis was performed to analyze the relationship between the changes in the TyG index and changes in other variables.
P < .05 was considered statistically significant.